Diabetes Insights - Breakthroughs and Innovators Podcast Por EASD - European Association for the Study of Diabetes arte de portada

Diabetes Insights - Breakthroughs and Innovators

Diabetes Insights - Breakthroughs and Innovators

De: EASD - European Association for the Study of Diabetes
Escúchala gratis

Acerca de esta escucha

EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at the EASD Annual Meeting 2024 in Madrid, Spain. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/home.html). New episode released every Friday. Ciencia
Episodios
  • Advances in Diabetes Care: Technology in Hospitals, Pregnancy & Gestational Diabetes
    May 23 2025
    In this episode, Professors Hood Thabit (University of Manchester, UK) and Helen Murphy (University of East Anglia, Norwich, UK) join Vivienne Parry and EASD to discuss the opportunities and persistent challenges in diabetes care in hospitals and pregnancy. The conversation examines how diabetes technology - from continuous glucose monitoring (CGM) to hybrid closed-loop systems - is improving outcomes for people with diabetes in inpatient settings and for pregnant women with type 1 diabetes. The guests reflect on recent advances, national implementation success stories from the NHS, and gaps that still exist in gestational and type 2 diabetes care. A compelling discussion on the balance between innovation, infrastructure, and integrated care. #Diabetes #Type1Diabetes #GestationalDiabetes #CGM #InpatientCare #PregnancyCare #DigitalHealth #Podcast
    Más Menos
    16 m
  • The Rise of GIP: From Biology to Medicine
    May 16 2025
    In this episode, we explore the fascinating history, fall, and resurgence of GIP (glucose-dependent insulinotropic polypeptide) in diabetes therapy. Once overshadowed by GLP-1, GIP is now back in the spotlight, thanks to dual and triple agonist therapies like tirzepatide. Experts discuss how GIP signaling in the brain may influence appetite and weight regulation, why early studies underestimated its therapeutic value, and what the future holds for multi-agonist drug development in metabolic disease. Join Prof. Michael Nauck from the University of Bochum, Dr. Alice Adriaenssens from UCL and our host, Vivienne Perry as they revisit the incretin story, unpack recent breakthroughs in GIP biology, and offer a glimpse into the next wave of gut hormone-based therapies that go beyond glucose control to address obesity and energy expenditure. #Diabetes #Type2Diabetes #IncretinTherapies #GIP #GLP1 #ObesityCare #Podcast
    Más Menos
    13 m
  • "Old and New" Islets for Type 1 Diabetes: From Transplant to Stem Cells
    May 9 2025
    In this episode, we explore the evolving world of cell therapy in type 1 diabetes. Professor James Shaw (Newcastle University), Dr Timothy Kieffer (University of British Columbia & Fractal Health), and Dr Trevor Reichman (University of Toronto) join EASD to discuss the established role of islet transplants and the exciting promise of stem cell–derived islets. The conversation covers the clinical realities of pancreas and islet cell transplants, the challenges of immunosuppression, and how scalable, gene-edited stem cell therapies could shape the future of diabetes care. From early trial successes to the potential of immune-evasive cells and gene therapies for GLP-1 delivery, today's episode examines what’s possible today and what’s coming next.
    Más Menos
    13 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones